Burford Brothers, Inc. Bristol Myers Squibb CO Transaction History
Burford Brothers, Inc.
- $206 Billion
- Q1 2025
A detailed history of Burford Brothers, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Burford Brothers, Inc. holds 6,726 shares of BMY stock, worth $313,767. This represents 0.2% of its overall portfolio holdings.
Number of Shares
6,726
Previous 6,720
0.09%
Holding current value
$313,767
Previous $380 Million
7.93%
% of portfolio
0.2%
Previous 0.19%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,810Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$8.93 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.4 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.04 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.42 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.1 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.2B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...